Adverse Event Reporting

VAERS ID 907101
Gender Female
Age 41
StateCode ME
Pharmaceutical Company PFIZER\BIONTECH
Lot Number EL1284
Number of vaccinations 1
Vaccinated 2020-12-22
Onset 2020-12-22
Condition Hospitalized Life Threatening Recovered
  • Hyperhidrosis
  • Nausea
  • Palpitations
  • Cough
  • Chest X-ray
  • Speech disorder

Current Illness

had been feeling slightly under the weather two weeks ago; no current asthma exacerbation, but has very labile asthma

Preexisting Conditions

Sleep apnea on CPAP eosinophilic asthma on multiple controller meds environmental allergies obesity

Other Medications

SIngulair, advair, Duonebs, dupixent, albuterol, zyrtec, chlorpheniramine; wellbutrin, Sertraline;

Previous Vaccinations


Anaphylaxis hx to NSAIDS; hs of environmental allergies, and reaction to latex

Laboratory Data

12/22/20 - CXR ordered - results not currently available


patient felt slightly nauseated at 10 minutes after injection, then developed slight sweating; BP 160/81; 83 at 5:45 and then 158/87 with HR 82 at 5: 52 pm.
Her lungs were clear, she was speaking in full sentences and was denying any chest pressure, her usual sense of asthma exacerbation.
At 6:05 it was 164/83 with HR 79 and patient developed a dry cough; we decided to have her wait just a bit longer, then cough worsened, so at 6:25, decision was made to have patient seen in ER for further assessment, and en route in wheelchair to ER the dry cough became persistent, spasmodic and patient was unable to speak.
Epi-Pen was injected in right mid thigh, and patient transported to ED urgent eval.
She noted immediate palpitations, and slight improvement of breahting, was able to speak in four word sentences.
On arrival to the ED, patient was administered Duonebs, Albuterol neb, IV Benedryl, IV Solumedrol; CXR was obtained, with results pending.
Patient was sent to observation for ongoing monitoring and assessment of breathing.
at 6:30 PM in the ER, she